2020
DOI: 10.1016/j.jconrel.2020.01.048
|View full text |Cite
|
Sign up to set email alerts
|

Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
89
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 131 publications
(90 citation statements)
references
References 37 publications
1
89
0
Order By: Relevance
“…Considering other MRI contrast agents, iron-oxide based materials are commonly used to shorten T 2 relaxation time, leading to a negative contrast [124]. A theranostic system based on superparamagnetic iron oxide (SPIO) and melanin was developed by Guan et al who loaded mesoporous polydopamine nanoparticles (MPDA NPs) with ultra-small SPIO NPs and a drug (sorafenib, SRF), by means of π-π stacking and/or hydrophobic interaction [125]. The advantage of these novel design was that NIR irradiation of SPIO-SRF and melanin could be exploited to induced ferroptosis and PTT respectively, while, simultaneously, SPIO NP could act as negative contrast agent for MRI, shortening T 2 relaxation time.…”
Section: Magnetic Resonance Imaging (Mri)mentioning
confidence: 99%
See 1 more Smart Citation
“…Considering other MRI contrast agents, iron-oxide based materials are commonly used to shorten T 2 relaxation time, leading to a negative contrast [124]. A theranostic system based on superparamagnetic iron oxide (SPIO) and melanin was developed by Guan et al who loaded mesoporous polydopamine nanoparticles (MPDA NPs) with ultra-small SPIO NPs and a drug (sorafenib, SRF), by means of π-π stacking and/or hydrophobic interaction [125]. The advantage of these novel design was that NIR irradiation of SPIO-SRF and melanin could be exploited to induced ferroptosis and PTT respectively, while, simultaneously, SPIO NP could act as negative contrast agent for MRI, shortening T 2 relaxation time.…”
Section: Magnetic Resonance Imaging (Mri)mentioning
confidence: 99%
“…Since 2017, Xing et al showed that PDA could be efficiently used in PTT-CT in order to fight multiple drugs resistance (MDR) cancer cells [198]. More recently, Guan et al developed a potent anticancer nanodrug by using mesoporous PDA NP for delivery of sorafenib (SRF, clinically-approved drug) and superparamagnetic iron oxide (SPIO) NP in order to induce ferroptosis of tumor cells [125]. Ferroptosis is an iron-dependent type of programmed cell death characterized by the accumulation of peroxides.…”
Section: Ptt-chemotherapymentioning
confidence: 99%
“…Nevertheless, in this model, the presence of IONs allowed them to trigger an additional photothermal effect (PTE). [ 40 ] The resulting multitherapeutic nanosystem was able to induce complete tumor destruction in vivo (HCT116) when the three killing effects were combined.…”
Section: Intracellular Chemodynamic Therapy: Ferroptosismentioning
confidence: 99%
“…Guan Q et al (2020) investigated mesoporous polydopamine carrying sorafenib and. Superparamagnetic iron oxide nanoparticles (SPION) for ferroptosis cancer therapy 36 . The heat generated due to laser irradiation of these particles offered a ferroptosis effect due to an increase in temperature.…”
Section: Superparamagnetic Npsmentioning
confidence: 99%